Per Kogner
Impact in
- Neurology top 0.2%
- Neuroblastoma Research and Treatments
- Microbiology top 0.5%
- Antimicrobial Peptides and Activities
Papers in
- Co-authors
- John Inge Johnsen (67 shared papers)Tommy Martinsson (62 shared papers)Baldur Sveinbjørnsson (31 shared papers)Helena Carén (15 shared papers)Frida Abel (12 shared papers)Frida Ponthan (18 shared papers)Lova Segerström (13 shared papers)Ninib Baryawno (13 shared papers)
- Journals
- International Journal of Cancer (14 papers)British Journal of Cancer (12 papers)European Journal of Cancer (10 papers)International Journal of Oncology (8 papers)Proceedings of the National Academy of Sciences (8 papers)
- Partner nations
- SwedenNorwayUnited States
In The Last Decade
Per Kogner
245 papers receiving 9.8k citations
Peers
Comparison fields: 5 of 129
- Neurology 3.8k
- Microbiology 486
- Cancer Research 905
- Genetics 451
- Oncology 903
Countries citing papers authored by Per Kogner
This map shows the geographic impact of Per Kogner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Kogner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Kogner more than expected).
Fields of papers citing papers by Per Kogner
This network shows the impact of papers produced by Per Kogner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Kogner. The network helps show where Per Kogner may publish in the future.
Co-authors
The 25 scholars most cited alongside Per Kogner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 249 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 423 | |
| 2 | 2014 | 286 | |
| 3 | 2017 | 273 | |
| 4 | 2008 | 222 | |
| 5 | 2010 | 218 | |
| 6 | 2015 | 208 | |
| 7 | 2013 | 202 | |
| 8 | 2010 | 186 | |
| 9 | Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. | 1993 | 185 |
| 10 | 2006 | 170 | |
| 11 | 2011 | 169 | |
| 12 | 2014 | 167 | |
| 13 | 2007 | 145 | |
| 14 | 2021 | 125 | |
| 15 | 2009 | 124 | |
| 16 | 2016 | 118 | |
| 17 | 2001 | 116 | |
| 18 | 2010 | 112 | |
| 19 | 2018 | 112 | |
| 20 | 2017 | 111 |
About Per Kogner
Per Kogner is a scholar working on Neurology, Oncology, Cancer Research, Genetics and Molecular Biology, having authored 249 papers that have together received 10k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (174 papers), Inflammatory mediators and NSAID effects (9 papers), Glioma Diagnosis and Treatment (8 papers), Neuropeptides and Animal Physiology (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Cancer-related Molecular Pathways (6 papers), Fatty Acid Research and Health (6 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Neurology (3.8k citations), Microbiology (486 citations), Cancer Research (905 citations), Genetics (451 citations) and Oncology (903 citations). Per Kogner has collaborated with scholars based in Sweden, Norway and United States. Frequent co-authors include John Inge Johnsen, Tommy Martinsson, Baldur Sveinbjørnsson, Helena Carén, Frida Abel, Frida Ponthan, Lova Segerström, Ninib Baryawno, Malin Wickström and Magnus Lindskog. Their work appears in journals such as International Journal of Cancer, British Journal of Cancer, European Journal of Cancer, International Journal of Oncology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.